Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification
- PMID: 20817886
- DOI: 10.1177/1087057110375614
Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification
Abstract
Fragment-based drug discovery (FBDD) has become a widely accepted tool that is complementary to high-throughput screening (HTS) in developing small-molecule inhibitors of pharmaceutical targets. Because a fragment campaign can only be as successful as the hit matter found, it is critical that the first stage of the process be optimized. Here the authors compare the 3 most commonly used methods for hit discovery in FBDD: high concentration screening (HCS), solution ligand-observed nuclear magnetic resonance (NMR), and surface plasmon resonance (SPR). They selected the commonly used saturation transfer difference (STD) NMR spectroscopy and the proprietary target immobilized NMR screening (TINS) as representative of the array of possible NMR methods. Using a target typical of FBDD campaigns, the authors find that HCS and TINS are the most sensitive to weak interactions. They also find a good correlation between TINS and STD for tighter binding ligands, but the ability of STD to detect ligands with affinity weaker than 1 mM K(D) is limited. Similarly, they find that SPR detection is most suited to ligands that bind with K(D) better than 1 mM. However, the good correlation between SPR and potency in a bioassay makes this a good method for hit validation and characterization studies.
Similar articles
-
Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.Methods Enzymol. 2011;493:469-85. doi: 10.1016/B978-0-12-381274-2.00018-2. Methods Enzymol. 2011. PMID: 21371602
-
From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance.Methods Enzymol. 2011;493:169-218. doi: 10.1016/B978-0-12-381274-2.00008-X. Methods Enzymol. 2011. PMID: 21371592
-
Experiences in fragment-based lead discovery.Methods Enzymol. 2011;493:509-31. doi: 10.1016/B978-0-12-381274-2.00020-0. Methods Enzymol. 2011. PMID: 21371604
-
SPR-based fragment screening: advantages and applications.Curr Top Med Chem. 2007;7(16):1630-42. doi: 10.2174/156802607782341073. Curr Top Med Chem. 2007. PMID: 17979772 Review.
-
Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.Top Curr Chem. 2012;317:115-43. doi: 10.1007/128_2011_225. Top Curr Chem. 2012. PMID: 21837555 Review.
Cited by
-
SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands.PLoS One. 2017 May 16;12(5):e0175842. doi: 10.1371/journal.pone.0175842. eCollection 2017. PLoS One. 2017. PMID: 28510609 Free PMC article.
-
FP Tethering: a screening technique to rapidly identify compounds that disrupt protein-protein interactions.Medchemcomm. 2014 Mar 1;5:370-375. doi: 10.1039/C3MD00356F. Medchemcomm. 2014. PMID: 24795804 Free PMC article.
-
NMR-based approaches for the identification and optimization of inhibitors of protein-protein interactions.Chem Rev. 2014 May 14;114(9):4749-63. doi: 10.1021/cr500043b. Epub 2014 Apr 8. Chem Rev. 2014. PMID: 24712885 Free PMC article. Review. No abstract available.
-
Applications of Solution NMR in Drug Discovery.Molecules. 2021 Jan 22;26(3):576. doi: 10.3390/molecules26030576. Molecules. 2021. PMID: 33499337 Free PMC article. Review.
-
Exiting the tunnel of uncertainty: crystal soak to validated hit.Acta Crystallogr D Struct Biol. 2022 Nov 1;78(Pt 11):1294-1302. doi: 10.1107/S2059798322009986. Epub 2022 Oct 27. Acta Crystallogr D Struct Biol. 2022. PMID: 36322414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials